Stereotactic ablative body radiation therapy (SABR) in NSW

被引:0
|
作者
Elizabeth R. Claridge Mackonis
Nicholas Hardcastle
Annette Haworth
机构
[1] Chris O’Brien Lifehouse,Department of Radiation Oncology
[2] University of Sydney,School of Physics
[3] Peter MacCallum Cancer Centre,Physical Sciences
来源
Physical and Engineering Sciences in Medicine | 2020年 / 43卷
关键词
SABR; SBRT; Stereotactic body radiation therapy; NSW; Survey;
D O I
暂无
中图分类号
学科分类号
摘要
A survey was conducted to establish the current utilisation of stereotactic ablative radiation therapy (SABR) services in NSW. The objective of the survey was to generate baseline data to inform requirements for a networked approach to the implementation of new radiation therapy techniques and technologies. All radiation therapy services in NSW were contacted by email with a request to complete a SABR service survey. Questions were designed to identify equipment used, treatment techniques in place, clinical sites treated with a SABR technique and plans to expand the current services offered. Each professional group was asked to identify areas of service delivery they would most like to improve. Sixteen responses were received representing 24 of 27 (89%) of NSW radiation therapy centres. The results indicate that most centres now treat with SABR, however the number of centres and the treatment sites are still increasing. VMAT treatments and 3D imaging are now commonplace. Liver was the most commonly reported treatment site where confidence in service delivery needed improvement. Data from the survey will be useful in formulating future collaborative and educational activities aimed at improving safety and efficacy in SABR service delivery to all patients in NSW and potentially the rest of the country.
引用
收藏
页码:641 / 650
页数:9
相关论文
共 50 条
  • [41] Safety of Pembrolizumab Combined with Stereotactic Ablative Body Radiotherapy (SABR) for Pulmonary Oligometastases
    Siva, S.
    Bressel, M.
    Loi, S.
    Sandhu, S.
    Tran, B.
    Mooi, J.
    Lewin, J.
    Azad, A.
    Colyer, D.
    Shaw, M.
    Chander, S.
    Cuff, K.
    Wood, S.
    Lawrentschuk, N.
    Murphy, D.
    Pryor, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S248 - S248
  • [42] Spine Stereotactic Ablative Body Radiation Therapy (SABR) With Volumetric Modulated Arc Therapy (VMAT) for Vertebral Metastases With and Without Metastatic Spinal Cord Compression (MSCC)
    Gestaut, M. M.
    Thawani, N.
    Kim, S.
    Gutti, V. R.
    Morrow, A.
    Ward, R. A.
    Huang, J. H.
    Patel, M. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E517 - E518
  • [43] Outcomes of Multiple/All lesions Stereotactic Ablative Radiation Therapy (SABR) for Oligo-Metastatic Renal Cancer
    Ma, M. W.
    Liu, M. Z.
    Li, H. Z.
    Gao, X. S.
    Yin, H.
    Yang, K. W.
    Wang, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E208 - E208
  • [44] EFFICACY AND TOXICITY OUTCOMES OF STEREOTACTIC ABLATIVE RADIATION THERAPY (LIGHT-SABR) FOR METASTATIC AND/OR RECURRENT PEDIATRIC CANCERS
    Upadhyay, Rituraj
    Matsui, Jennifer
    Chakravarthi, Vikram
    Scharschmidt, Thomas
    Yeager, Nicholas
    Setty, Bhuvana
    Cripe, Timothy
    Roberts, Ryan
    Aldrink, Jennifer
    Baliga, Sujith
    Palmer, Joshua
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S71 - S72
  • [45] Esophagitis in Patients Treated with Thoracic Stereotactic Ablative Radiation Therapy (SABR) to Tumors within 2 cm of the Esophagus
    Quaovi, S.
    Ko, R.
    Bush, K.
    Binkley, M. S.
    Pickthorn, W.
    Maxim, P. G.
    Gensheimer, M. F.
    Diehn, M.
    Loo, B. W., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E666 - E666
  • [46] Stereotactic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of a Randomized Trial
    Palma, D. A.
    Olson, R. A.
    Harrow, S.
    Gaede, S.
    Louie, A. V.
    Haasbeek, C.
    Mulroy, L. A.
    Lock, M. I.
    Rodrigues, G.
    Yaremko, B. P.
    Schellenberg, D.
    Ahmad, B.
    Griffioen, G.
    Senthi, S.
    Liu, M. C.
    Moore, K.
    Currie, S.
    Bauman, G. S.
    Warner, A.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S3 - S4
  • [47] Outcomes of Pediatric and Adolescent Patients with Metastatic Sarcoma Treated with Surgical Resection or Stereotactic Ablative Radiation Therapy (SABR)
    Oh, Justin
    Gutkin, Paulina
    Donaldson, Sarah
    Steffner, Robert
    Bruzoni, Matias
    Avedian, Raffi
    Spunt, Sheri
    Pribnow, Allison
    Hiniker, Susan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (09): : S42 - S42
  • [48] Stereotactic ablative body radiation therapy for spinal metastases; A single institution study
    McNulty, M.
    Waldron, O.
    Ather, M.
    Rangaswamy, G.
    Houlihan, O.
    Dunne, M.
    Curran, B.
    Ryan, S.
    Skourou, C.
    El Beltagi, N.
    Fitzpatrick, D.
    O'Sullivan, S.
    Faul, C.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S969 - S969
  • [49] Pseudoprogression of a spinal metastasis after stereotactic ablative body radiation therapy and immune checkpoint therapy
    Jhawar, Sachin R.
    Silk, Ann W.
    Goyal, Sharad
    PRACTICAL RADIATION ONCOLOGY, 2017, 7 (02) : 109 - 112
  • [50] Phase II trial of stereotactic ablative radiation (SAbR) for oligoprogressive kidney cancer.
    Hannan, Raquibul
    Christensen, Michael
    Garant, Aurelie
    Hammers, Hans J.
    Arafat, Waddah
    Courtney, Kevin Dale
    Bowman, Isaac Alex
    Cole, Suzanne
    Sher, David
    Ahn, Chul
    Timmerman, Robert D.
    Brugarolas, James
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)